Developer docs
API playgroundTry for free, no card

Search company profiles

Sotex

Full company profile

uuid003j1fo

Namestring
Sotex
Legal namestring
ЗАО "ФармФирма "Сотекс"
Websiteurl
sotex.ru
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Sotex (ZAO PharmFirma Sotex) is a Russian full-cycle pharmaceutical manufacturer founded in 1999 and headquartered in Moscow. Operating as the foundation of the production segment of PROTEK Group, a diversified pharmaceutical conglomerate, the company specializes in injectable drugs — ampoules, prefilled syringes with needle protection devices, and biotechnological products — across therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology. Its Belikovo production facility in the Moscow region, commissioned in 2005 and built to EU GMP standards, produces 143 million ampoules and 13 million prefilled syringes annually, and the company holds European GMP certifications from Croatia and Portugal as well as EAEU GMP certification from the Russian Ministry of Industry and Trade. The portfolio exceeds 150 product positions including the proprietary original drug Tafalgin, with more than 50 products in the R&D pipeline, and through its Rafarma subsidiary (acquired 2011) the group extends into oncological drugs, antibiotics, and contract manufacturing for third parties.

Sotex generates revenue primarily through pharmaceutical product sales via two channels: Russian state procurement under the Essential Medicines List (ZhNVLP) through competitive tenders, and commercial distribution to hospitals, clinics, and pharmacies across all regions of Russia. The company has confirmed full production cycle status for 169 international non-proprietary names and ranks 5th among Russian full-cycle pharmaceutical manufacturers in government procurement per Minpromtorg, placing it within a 116.9 billion ruble state procurement pool in 2025. The second growth vector is international — products are exported to 20 countries including EU member states, with the first EU shipment completed in 2023 and Belarus market entry in 2024. The go-to-market motion combines medical representative engagement with healthcare professionals, government tender participation, and channel distribution partnerships with international pharmaceutical companies including Synthon, Intas, Emcure, Glenmark, and Pharos. PROTEK Group's holding structure provides Sotex with access to complementary subsidiaries (Rafarma, AnviLab, Protein Contour, Protek-SVM, BION) that expand the addressable product surface beyond Sotex's own injectable specialization.

Short descriptiontext

Sotex is a Moscow-based Russian full-cycle pharmaceutical manufacturer specializing in injectable and biotechnological drugs, operating as the production core of PROTEK Group. It supplies 150+ products across neurology, oncology, and nephrology to government healthcare programs and exports to 20 countries including EU member states.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMoscow, Russia
HQ citystring
Moscow
HQ countrystring
Russia
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
injectable pharmaceuticals, biotechnological drugs, prefilled syringes, pharmaceutical manufacturing, generic medications
Industry3 codes
PRIMARYHLAAAKAB
Drug Product Fill-Finish & Aseptic Manufacturing Services
SECONDARYHLAGAGAG
Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAJAG
Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Biological Products, (No Disgnostic Substances)2836
Product category
Pharmaceutical Manufacturing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Pharmaceutical product sales
TypeOne Time License
Description

Sale of pharmaceutical products across therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology. Products are sold through government procurement (state tenders) and commercial distribution channels. The company has a portfolio of more than 150 product positions.

sotex.ru
2Contract manufacturing
TypeProfessional Services
Description

Rafarma offers contract manufacturing services to third-party pharmaceutical companies.

sotex.ru
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1Government procurement / regulated pricing
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Products are procured through government tenders and regulated pricing under the Essential Medicines List (ZhNVLP). State procurement volume for products with confirmed full production cycle in 2025 amounted to 116.9 billion rubles.

career.sotex.ru
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Sotex (ЗАО «ФармФирма «Сотекс») is a Russian full-cycle pharmaceutical manufacturer specializing in injectable drugs, biotechnological products, and prefilled syringes. The company produces more than 150 pharmaceutical product positions across therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology, with annual capacity of 143 million ampules and 13 million prefilled syringes. Operations are GMP-certified under Russian and EU standards, and products are supplied domestically via government procurement and commercially, as well as exported to 20 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 143 million ampules produced annually
+4 more records
Product overview1 text field

Sotex is a Russian pharmaceutical company operating as part of the PROTEK Group's production segment. The company offers a diversified portfolio of over 150 pharmaceutical products across multiple therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology. The product portfolio includes prescription and OTC drugs available in various forms: injectables (ampules, pre-filled syringes), tablets, capsules, suppositories, and gels. Key products include original medications like Тафлгин®, биотехнологические препараты such as Эральфон® (epoetin alfa), and a wide range of generic medications. The company operates two production facilities: Sotex (specializing in injectables - ampules and syringes, producing 143 million ampules and 13 million syringes annually) and Rafarma (producing oncological drugs, antibiotics, tablets, capsules, suppositories, and gels). Sotex provides contract manufacturing services and holds GMP certifications from Russian and EU regulatory bodies.

Product and service3 records
1Eralfon (Эральфон®)
CategoryPrescription biotechnology drug
Description

Recombinant erythropoietin (epoetin alfa) in prefilled syringe form for the treatment of anemia in oncology and nephrology patients. For healthcare providers and patients.

2Tafalgin (Тафалгин®)
CategoryPrescription original drug
Description

Original proprietary drug developed and registered by Sotex in injectable form.

3Amelotex (Амелотекс®)
Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierKeyTypeStrategic or Co-development Partner
Description

Synthon is an international science-oriented pharmaceutical company. Sotex collaborates with Synthon on the Russian market development and distribution of pharmaceutical products.

Strategic tierKeyTypeStrategic or Co-development Partner
Description

Intas is a pharmaceutical company engaged in the development, manufacturing and marketing of a wide range of biopharmaceutical products worldwide. Sotex collaborates with Intas on the Russian market.

Strategic tierKeyTypeStrategic or Co-development Partner
Description

Emcure is engaged in the development, manufacturing and marketing of biopharmaceutical products worldwide. Sotex collaborates with Emcure on the Russian market.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharos is an international pharmaceutical company. Sotex collaborates with Pharos on the Russian market.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Glenmark is an international pharmaceutical company specializing in R&D. Sotex collaborates with Glenmark on the Russian market.

6Rafarma
Strategic tierKeyTypeStrategic or Co-development Partner
Description

Rafarma (AO Rafarma) is a production subsidiary of GK Protek, producing oncological drugs and antibiotics at full cycle. Companies jointly develop target education programs, organize professional orientation events for schoolchildren, and participate in joint initiatives including FarmFest festival and GxP-Fest.

sotex.ru
7GK Protek (ГК Протек)
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

GK Protek is the parent holding company of Sotex and the production segment it anchors. Protek Group includes companies: Sotex, Rafarma, AnviLab, Protein Contour, Protek-SVM, BION, and strategic partner Active Component. Sotex is the foundation of the production segment of GK Protek.

sotex.ru
8Евразийская академия надлежащих практик (ANO EANP)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Eurasian Academy of Good Practices provides educational programs, supports GxP-Fest and FarmFest festivals, and collaborated on VR training complex development. One of the first organizations to partner with Sotex on innovative training technologies.

career.sotex.ru
9Благотворительный фонд «Протек»
Strategic tierKeyTypeStrategic or Co-development Partner
Description

Charitable Foundation of Protek Group implements charity programs including 'Along the Path of Mercy' program. Joint activities with Sotex include support for children's, medical and educational institutions.

career.sotex.ru
10ФБУ ГИЛС и НП (Государственный институт лекарственных средств и надлежащих практик)
Strategic tierCoreTypeOthers
Description

Federal Budgetary Institution for pharmaceutical industry development. GLLS&NP organizes the GxP-Fest festival and serves as the Russian GMP inspectorate under the Ministry of Industry and Trade. Company CEO Vadim Yatsuk spoke at a GxP-Fest session on digital development in pharma.

career.sotex.ru
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Russian biotech manufacturer focused on biosimilars, blood products, and complex injectables. Comparable to Sotex in biopharmaceutical manufacturing capability and prefilled syringe/aseptic fill-finish expertise.

TypeDirect peer
Description

Russian full-cycle manufacturer of generics and branded generics (Polpharma subsidiary). Competes directly with Sotex in Russian state procurement and shares similar reliance on ZhNVLP pricing and contract manufacturing exposure.

TypeDirect peer
Description

Russian biotech company developing and manufacturing biosimilars, mAbs, and ATMPs. Comparable to Sotex in prefilled syringe biotech manufacturing and government channel for biological products, though more biologics-concentrated.

4Polysan
TypeDirect peer
Description

Russian pharmaceutical manufacturer with branded generics in neurology, infectious disease, and immunology. Comparable therapeutic-area focus and similar mid-tier scale in Russian state procurement.

TypeDirect peer
Description

Russian full-cycle pharmaceutical manufacturer with branded prescription portfolio spanning neurology, immunology, and anti-infectives. Directly comparable in scale, therapeutic focus, and ZhNVLP government channel exposure.

TypeDirect peer
Description

Russia's largest full-cycle pharmaceutical manufacturer, listed on the Moscow Exchange. Competes with Sotex across prescription generics, injectables, and Essential Medicines List procurement in the same therapeutic categories.

TypeEmerging player
Description

Russian pharmaceutical development and manufacturing company with R-Pharm backing. Smaller scale but overlapping in injectable pharmaceutical manufacturing and partnership-based business model.

TypeDirect peer
Description

Russian pharmaceutical manufacturer of generic injectables, tablets, and oncology products (Abbott subsidiary). Direct overlap with Sotex in injectable generics and government procurement participation.

TypeBroad incumbent
Description

One of Russia's largest pharmaceutical groups with operations spanning manufacturing, R&D, and distribution. Larger and more diversified than Sotex but competes in the same full-cycle generics and biologics categories.

10Obolenskoe Pharmaceutical Enterprise
TypeEmerging player
Description

Russian manufacturer of finished dosage forms including injectables and solid forms. Competes in similar generics categories and ZhNVLP tenders, though at smaller scale than Sotex.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sotex

Pharmaceutical Manufacturingsotex.ru

Sotex is a Moscow-based Russian full-cycle pharmaceutical manufacturer specializing in injectable and biotechnological drugs, operating as the production core of PROTEK Group. It supplies 150+ products across neurology, oncology, and nephrology to government healthcare programs and exports to 20 countries including EU member states.

What Sotex does

Sotex (ZAO PharmFirma Sotex) is a Russian full-cycle pharmaceutical manufacturer founded in 1999 and headquartered in Moscow. Operating as the foundation of the production segment of PROTEK Group, a diversified pharmaceutical conglomerate, the company specializes in injectable drugs — ampoules, prefilled syringes with needle protection devices, and biotechnological products — across therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology. Its Belikovo production facility in the Moscow region, commissioned in 2005 and built to EU GMP standards, produces 143 million ampoules and 13 million prefilled syringes annually, and the company holds European GMP certifications from Croatia and Portugal as well as EAEU GMP certification from the Russian Ministry of Industry and Trade. The portfolio exceeds 150 product positions including the proprietary original drug Tafalgin, with more than 50 products in the R&D pipeline, and through its Rafarma subsidiary (acquired 2011) the group extends into oncological drugs, antibiotics, and contract manufacturing for third parties.

Sotex generates revenue primarily through pharmaceutical product sales via two channels: Russian state procurement under the Essential Medicines List (ZhNVLP) through competitive tenders, and commercial distribution to hospitals, clinics, and pharmacies across all regions of Russia. The company has confirmed full production cycle status for 169 international non-proprietary names and ranks 5th among Russian full-cycle pharmaceutical manufacturers in government procurement per Minpromtorg, placing it within a 116.9 billion ruble state procurement pool in 2025. The second growth vector is international — products are exported to 20 countries including EU member states, with the first EU shipment completed in 2023 and Belarus market entry in 2024. The go-to-market motion combines medical representative engagement with healthcare professionals, government tender participation, and channel distribution partnerships with international pharmaceutical companies including Synthon, Intas, Emcure, Glenmark, and Pharos. PROTEK Group's holding structure provides Sotex with access to complementary subsidiaries (Rafarma, AnviLab, Protein Contour, Protek-SVM, BION) that expand the addressable product surface beyond Sotex's own injectable specialization.

Sotex firmographics

Firmographics
Name
Sotex
Legal name
ЗАО "ФармФирма "Сотекс"
Website
https://sotex.ru
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
101–250 employees
Short description
Sotex is a Moscow-based Russian full-cycle pharmaceutical manufacturer specializing in injectable and biotechnological drugs, operating as the production core of PROTEK Group. It supplies 150+ products across neurology, oncology, and nephrology to government healthcare programs and exports to 20 countries including EU member states.
Ownership category
akta.pro rank

Sotex industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAAKAB
Drug Product Fill-Finish & Aseptic Manufacturing Services
SECONDARYHLAGAGAG
Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAJAG
Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Injectable pharmaceuticals
  • Biotechnological drugs
  • Prefilled syringes
  • Pharmaceutical manufacturing
  • Generic medications

Where Sotex is headquartered

Location

Headquarters

HQ city
Moscow
HQ country
Russia
HQ region
Europe

Offices3 records

Markets served

Sotex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical product sales: Sale of pharmaceutical products across therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology. Products are sold through government procurement (state tenders) and commercial distribution channels. The company has a portfolio of more than 150 product positions.
  2. Contract manufacturing: Rafarma offers contract manufacturing services to third-party pharmaceutical companies.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goGovernment procurement / regulated pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Sotex product offering

Product offering

Core offering

Sotex (ЗАО «ФармФирма «Сотекс») is a Russian full-cycle pharmaceutical manufacturer specializing in injectable drugs, biotechnological products, and prefilled syringes. The company produces more than 150 pharmaceutical product positions across therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology, with annual capacity of 143 million ampules and 13 million prefilled syringes. Operations are GMP-certified under Russian and EU standards, and products are supplied domestically via government procurement and commercially, as well as exported to 20 countries.

Product overview

Sotex is a Russian pharmaceutical company operating as part of the PROTEK Group's production segment. The company offers a diversified portfolio of over 150 pharmaceutical products across multiple therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology. The product portfolio includes prescription and OTC drugs available in various forms: injectables (ampules, pre-filled syringes), tablets, capsules, suppositories, and gels. Key products include original medications like Тафлгин®, биотехнологические препараты such as Эральфон® (epoetin alfa), and a wide range of generic medications. The company operates two production facilities: Sotex (specializing in injectables - ampules and syringes, producing 143 million ampules and 13 million syringes annually) and Rafarma (producing oncological drugs, antibiotics, tablets, capsules, suppositories, and gels). Sotex provides contract manufacturing services and holds GMP certifications from Russian and EU regulatory bodies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Eralfon (Эральфон®) Recombinant erythropoietin (epoetin alfa) in prefilled syringe form for the treatment of anemia in oncology and nephrology patients. For healthcare providers and patients.
  • Tafalgin (Тафалгин®) Original proprietary drug developed and registered by Sotex in injectable form.
  • Amelotex (Амелотекс®)

Quantifiable outcome

  • 143 million ampules produced annually
  • +4 more outcomes

Companies that use Sotex

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles3 records

Sotex technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Sotex partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered key, core and flagship.

  • SynthonkeyStrategic or Co-development PartnerSynthon is an international science-oriented pharmaceutical company. Sotex collaborates with Synthon on the Russian market development and distribution of pharmaceutical products.
  • Intas PharmaceuticalskeyStrategic or Co-development PartnerIntas is a pharmaceutical company engaged in the development, manufacturing and marketing of a wide range of biopharmaceutical products worldwide. Sotex collaborates with Intas on the Russian market.
  • Emcure PharmaceuticalskeyStrategic or Co-development PartnerEmcure is engaged in the development, manufacturing and marketing of biopharmaceutical products worldwide. Sotex collaborates with Emcure on the Russian market.
  • Pharos Pharmaceutical GroupcoreStrategic or Co-development PartnerPharos is an international pharmaceutical company. Sotex collaborates with Pharos on the Russian market.
  • Glenmark PharmaceuticalscoreStrategic or Co-development PartnerGlenmark is an international pharmaceutical company specializing in R&D. Sotex collaborates with Glenmark on the Russian market.
  • RafarmakeyStrategic or Co-development PartnerRafarma (AO Rafarma) is a production subsidiary of GK Protek, producing oncological drugs and antibiotics at full cycle. Companies jointly develop target education programs, organize professional orientation events for schoolchildren, and participate in joint initiatives including FarmFest festival and GxP-Fest.
  • GK Protek (ГК Протек)flagshipStrategic or Co-development PartnerGK Protek is the parent holding company of Sotex and the production segment it anchors. Protek Group includes companies: Sotex, Rafarma, AnviLab, Protein Contour, Protek-SVM, BION, and strategic partner Active Component. Sotex is the foundation of the production segment of GK Protek.
  • Евразийская академия надлежащих практик (ANO EANP)coreStrategic or Co-development PartnerEurasian Academy of Good Practices provides educational programs, supports GxP-Fest and FarmFest festivals, and collaborated on VR training complex development. One of the first organizations to partner with Sotex on innovative training technologies.
  • Благотворительный фонд «Протек»keyStrategic or Co-development PartnerCharitable Foundation of Protek Group implements charity programs including 'Along the Path of Mercy' program. Joint activities with Sotex include support for children's, medical and educational institutions.
  • ФБУ ГИЛС и НП (Государственный институт лекарственных средств и надлежащих практик)coreOthersFederal Budgetary Institution for pharmaceutical industry development. GLLS&NP organizes the GxP-Fest festival and serves as the Russian GMP inspectorate under the Ministry of Industry and Trade. Company CEO Vadim Yatsuk spoke at a GxP-Fest session on digital development in pharma.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Sotex competitors and assessment

Company assessment

Direct peers

  • Generium: Russian biotech manufacturer focused on biosimilars, blood products, and complex injectables. Comparable to Sotex in biopharmaceutical manufacturing capability and prefilled syringe/aseptic fill-finish expertise.
  • Akrikhin: Russian full-cycle manufacturer of generics and branded generics (Polpharma subsidiary). Competes directly with Sotex in Russian state procurement and shares similar reliance on ZhNVLP pricing and contract manufacturing exposure.
  • Biocad: Russian biotech company developing and manufacturing biosimilars, mAbs, and ATMPs. Comparable to Sotex in prefilled syringe biotech manufacturing and government channel for biological products, though more biologics-concentrated.
  • Polysan: Russian pharmaceutical manufacturer with branded generics in neurology, infectious disease, and immunology. Comparable therapeutic-area focus and similar mid-tier scale in Russian state procurement.
  • Valenta Pharm: Russian full-cycle pharmaceutical manufacturer with branded prescription portfolio spanning neurology, immunology, and anti-infectives. Directly comparable in scale, therapeutic focus, and ZhNVLP government channel exposure.
  • Pharmstandard: Russia's largest full-cycle pharmaceutical manufacturer, listed on the Moscow Exchange. Competes with Sotex across prescription generics, injectables, and Essential Medicines List procurement in the same therapeutic categories.
  • Vertex (Veropharm): Russian pharmaceutical manufacturer of generic injectables, tablets, and oncology products (Abbott subsidiary). Direct overlap with Sotex in injectable generics and government procurement participation.

Emerging players

  • NovaMedica: Russian pharmaceutical development and manufacturing company with R-Pharm backing. Smaller scale but overlapping in injectable pharmaceutical manufacturing and partnership-based business model.
  • Obolenskoe Pharmaceutical Enterprise: Russian manufacturer of finished dosage forms including injectables and solid forms. Competes in similar generics categories and ZhNVLP tenders, though at smaller scale than Sotex.

Broad incumbents

  • R-Pharm: One of Russia's largest pharmaceutical groups with operations spanning manufacturing, R&D, and distribution. Larger and more diversified than Sotex but competes in the same full-cycle generics and biologics categories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Sotex social profiles

Digital presence

Sotex compliance and trust

Trust signal

Compliance3 records

Sotex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sotex leadership team

Management profile

Number of profiles

Profiles8 records

Sotex subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Sotex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sotex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sotex

What does Sotex do?

Sotex (ЗАО «ФармФирма «Сотекс») is a Russian full-cycle pharmaceutical manufacturer specializing in injectable drugs, biotechnological products, and prefilled syringes. The company produces more than 150 pharmaceutical product positions across therapeutic areas including neurology, oncology, rheumatology, nephrology, and psychoneurology, with annual capacity of 143 million ampules and 13 million prefilled syringes. Operations are GMP-certified under Russian and EU standards, and products are supplied domestically via government procurement and commercially, as well as exported to 20 countries.

Is Sotex a public or private company?

Sotex is a private company. It is classified as corporate owned and is currently operating.

When was Sotex founded?

Sotex was founded in 1999. It employs 101 to 250 people.

Where is Sotex based?

Sotex is headquartered in Moscow, Russia, in the Europe region.

How does Sotex make money?

Two revenue lines are on record. Pharmaceutical product sales are the primary driver. The others are contract manufacturing.

Who are Sotex's main competitors?

Direct peers on record are Generium, Akrikhin, Biocad, Polysan, Valenta Pharm, Pharmstandard and Vertex (Veropharm). Emerging players are NovaMedica and Obolenskoe Pharmaceutical Enterprise. R-Pharm is listed as a broad incumbent.

Does Sotex have an API?

No public API is recorded for Sotex.

What industry is Sotex in?

Sotex's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAAAKAB, Drug Product Fill-Finish & Aseptic Manufacturing Services, with a secondary code of HLAGAGAG, Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales